Literature DB >> 7710937

Adjuvant intraoperative photodynamic therapy diminishes the rate of local recurrence in a rat mammary tumour model.

R van Hillegersberg1, J M Hekking-Weijma, J H Wilson, A Edixhoven-Bosdijk, W J Kort.   

Abstract

The use of photodynamic therapy (PDT) as an adjunct to curative tumour resection was investigated in a tumour recurrence model, using rat mammary adenocarcinoma BN472. Tumours were inoculated subcutaneously in 60 animals and resected after 21 days of growth. Immediately after removal, the operation site was exposed to 320-450 nm light of 0.1 W cm-2 and 60 J cm-2 after photosensitisation with either Photofrin (5 mg kg-1 i.v. 48 h before illumination) or 5-aminolaevulinic acid (ALA) (2 mg ml-1 in drinking water for 9 days). Porphyrin concentrations were measured in tissue samples. After 28 days, animals treated with adjunctive PDT had a significantly longer tumour-free interval than controls (P < 0.01); median 25 days (Photofrin), 18 days (ALA), 14 days (controls). Moreover, in the PDT groups significantly fewer rats had lymph node metastasis. A prophyrin concentration ratio between tumour and mammary tissue of 2:1 was found after Photofrin and 4:1 after ALA. The results indicate that adjuvant intraoperative PDT may be a safe and effective method of destroying residual tumour, thereby preventing locoregional tumour recurrence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7710937      PMCID: PMC2033744          DOI: 10.1038/bjc.1995.143

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  39 in total

1.  Patterns of recurrence after curative resection of carcinoma of the colon and rectum.

Authors:  S Galandiuk; H S Wieand; C G Moertel; S S Cha; R J Fitzgibbons; J H Pemberton; B G Wolff
Journal:  Surg Gynecol Obstet       Date:  1992-01

Review 2.  Management of local and regional recurrence after mastectomy or breast-conserving treatment.

Authors:  F C Ames; C M Balch
Journal:  Surg Clin North Am       Date:  1990-10       Impact factor: 2.741

3.  Photodestruction of tumor cells by induction of endogenous accumulation of protoporphyrin IX: enhancement by 1,10-phenanthroline.

Authors:  N Rebeiz; C C Rebeiz; S Arkins; K W Kelley; C A Rebeiz
Journal:  Photochem Photobiol       Date:  1992-03       Impact factor: 3.421

4.  Wavelength dependence of hematoporphyrin derivative photodynamic treatment effects on rat ears.

Authors:  W Star; J Versteeg; W van Putten; H Marijnissen
Journal:  Photochem Photobiol       Date:  1990-09       Impact factor: 3.421

5.  Intraoperative phototherapy (PDT) and surgical resection in a mouse neuroblastoma model.

Authors:  R K Davis; L F Smith; R F Thurgood; Z Kereszti; R C Straight
Journal:  Lasers Surg Med       Date:  1990       Impact factor: 4.025

6.  Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats.

Authors:  R Van Hillegersberg; J W Van den Berg; W J Kort; O T Terpstra; J H Wilson
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

7.  Porphyrin synthesis by human hepatocytes and HepG2 cells--effects of enzyme inducers and delta-aminolevulinic acid.

Authors:  O Visser; J W van den Berg; H Koole-Lesuis; G Voortman; J H Wilson
Journal:  Toxicology       Date:  1991-03-25       Impact factor: 4.221

8.  An HPLC assay for rat liver ferrochelatase activity.

Authors:  F M Li; C K Lim; T J Peters
Journal:  Biomed Chromatogr       Date:  1987       Impact factor: 1.902

9.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

10.  Distribution and elimination of Photofrin II in mice.

Authors:  D A Bellnier; Y K Ho; R K Pandey; J R Missert; T J Dougherty
Journal:  Photochem Photobiol       Date:  1989-08       Impact factor: 3.421

View more
  5 in total

1.  Enhanced Efficacy of Photodynamic Therapy by Coupling a Cell-Penetrating Peptide with Methylene Blue.

Authors:  Jinhui Ser; Ji Yeon Lee; Yong Ho Kim; Hoonsung Cho
Journal:  Int J Nanomedicine       Date:  2020-08-06

2.  P2X7 receptor as a novel drug delivery system to increase the entrance of hydrophilic drugs into cells during photodynamic therapy.

Authors:  Paulo Anastácio Furtado Pacheco; Leonardo Braga Gomes Ferreira; Leonardo Mendonça; Dinarte Neto M Ferreira; Juliana Pimenta Salles; Robson Xavier Faria; Pedro Celso Nogueira Teixeira; Luiz Anastacio Alves
Journal:  J Bioenerg Biomembr       Date:  2016-07-15       Impact factor: 2.945

3.  Screening and In Vitro Evaluation of Mucoadhesive Thermoresponsive System Containing Methylene Blue for Local Photodynamic Therapy of Colorectal Cancer.

Authors:  Fernanda Belincanta Borghi-Pangoni; Mariana Volpato Junqueira; Sabrina Barbosa de Souza Ferreira; Larissa Lachi Silva; Bruno Ribeiro Rabello; Wilker Caetano; Andrea Diniz; Marcos Luciano Bruschi
Journal:  Pharm Res       Date:  2015-11-09       Impact factor: 4.200

Review 4.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

5.  Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model.

Authors:  A Obwegeser; R Jakober; H Kostron
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.